EichorEICHOR
Location: Hwasun Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Hwasun

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Chonnam National University Hwasun Hospital · Pfizer · NCT07028853This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Chonnam National University Hwasun Hospital · Pfizer · NCT06758401Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Chonnam National University Hwasun Hospital · Eli Lilly and Company · NCT06890598A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Chonnam National University Hwasun Hospital · Turning Point Therapeutics, Inc. · NCT03093116A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Hoffmann-La Roche · NCT04929223A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Chonnam National University Hwasun Hospital · Fore Biotherapeutics · NCT05503797A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · Chonnam National University Hwasun Hospital · Hoffmann-La Roche · NCT07416526A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Chonnam National University Hwasun Hospital · Celgene · NCT05519085Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
Phase 1/Phase 2 · Chonnam National University Hwasun Hospital · YOUNGIL KOH · NCT06645678Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal
Phase N/A · International Extranodal Lymphoma Study Group (IELSG) · NCT05700149A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 · Janssen Research & Development, LLC · NCT04634552Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Chonnam National University Hwasun Hospital · Kura Oncology, Inc. · NCT07007312A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Janssen Research & Development, LLC · NCT06319820A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR
Phase 2 · Chonnam National University Hwasun Hospital · Taiho Oncology, Inc. · NCT05967689Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · Chonnam National University Hwasun Hospital · Daiichi Sankyo · NCT06731478A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Chonnam National University Hwasun Hospital · Pfizer · NCT06629779BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Chonnam National University Hwasun Hospital · BeOne Medicines · NCT07492641A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Chonnam National University Hwasun Hospital · Bristol-Myers Squibb · NCT06561386DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Chonnam National University Hwasun Hospital · Boehringer Ingelheim · NCT07472517Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia
Phase 2 · Chonnam National University Hwasun Hospital · Yonsei University · NCT06516679Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENT
Phase 4 · Chonnam National University Hwasun Hospital · Seoul National University Hospital · NCT05845489Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Tr
Phase 3 · Hoffmann-La Roche · NCT07555938A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Chonnam National University Hwasun Hospital · Eli Lilly and Company · NCT06119581Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Chonnam National University Hwasun Hospital · Revolution Medicines, Inc. · NCT06881784Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Phase 2 · Chonnam National University Hwasun Hospital · Hanmi Pharmaceutical Company Limited · NCT07449754Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Chonnam National University Hwasun Hospital-Hemato-Oncology · Merck Sharp & Dohme LLC · NCT03486873A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · Chonnam National University Hwasun Hospital · Pfizer · NCT05623020A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · Site 51 · Merus B.V. · NCT06525220A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Chonnam National University Hwasun Hospital · Janssen Research & Development, LLC · NCT05552222A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · Chonnam National University Hwasun Hospital · Janssen Research & Development, LLC · NCT07518186
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.